Ziopharm Oncology reported $22.64M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Amgen AMGN:US $ 5.7B 1.93B
Arena Pharmaceuticals ARNA:US $ 144.39M 12.4M
AstraZeneca AZN:LN 7.09B 1.67B
Baxter International BAX:US $ 2674M 118M
Biogen BIIB:US $ 1984.9M 304.4M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Corcept Therapeutics CORT:US $ 59.64M 154K
Curis CRIS:US $ 12.94M 1.95M
Eleven Biotherapeutics EBIO:US 27.63M 31.9M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Immunogen IMGN:US $ 44.32M 305K
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
Intrexon XON:US $ 49.25M 7.06M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Merk MRK:US $ 9905M 839M
Novartis NOVN:VX 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Tg Therapeutics TGTX:US $ 79.04M 10.96M
Verastem VSTM:US $ 16.44M 1.33M
YTE INCY:US $ 564.87M 58.95M
Ziopharm Oncology ZIOP:US $ 22.64M 1.08M